OBJECTIVE: To determine optimal Pediatric Anxiety Rating Scale (PARS) percent reduction and raw score cut-offs for predicting treatment response and remission among children and adolescents with anxiety disorders. METHOD: Data were from a subset of youth (N = 438; 7-17 years of age) who participated in the Child/Adolescent Anxiety Multimodal Study (CAMS), a multi-site, randomized controlled trial that examined the relative efficacy of cognitive-behavioral therapy (CBT; Coping Cat), medication (sertraline [SRT]), their combination, and pill placebo for the treatment of separation anxiety disorder, generalized anxiety disorder, and social phobia. The clinician-rated PARS was administered pre- and posttreatment (delivered over 12 weeks). Quality receiver operating characteristic methods assessed the performance of various PARS percent reductions and absolute cut-off scores in predicting treatment response and remission, as determined by posttreatment ratings on the Clinical Global Impression scales and the Anxiety Disorders Interview Schedule for DSM-IV. Corresponding change in impairment was evaluated using the Child Anxiety Impact Scale. RESULTS: Reductions of 35% and 50% on the six-item PARS optimally predicted treatment response and remission, respectively. Post-treatment PARS raw scores of 8 to 10 optimally predicted remission. Anxiety improved as a function of PARS-defined treatment response and remission. CONCLUSIONS: Results serve as guidelines for operationalizing treatment response and remission in future research and in making cross-study comparisons. These guidelines can facilitate translation of research findings into clinical practice.
RCT Entities:
OBJECTIVE: To determine optimal Pediatric Anxiety Rating Scale (PARS) percent reduction and raw score cut-offs for predicting treatment response and remission among children and adolescents with anxiety disorders. METHOD: Data were from a subset of youth (N = 438; 7-17 years of age) who participated in the Child/Adolescent Anxiety Multimodal Study (CAMS), a multi-site, randomized controlled trial that examined the relative efficacy of cognitive-behavioral therapy (CBT; Coping Cat), medication (sertraline [SRT]), their combination, and pill placebo for the treatment of separation anxiety disorder, generalized anxiety disorder, and social phobia. The clinician-rated PARS was administered pre- and posttreatment (delivered over 12 weeks). Quality receiver operating characteristic methods assessed the performance of various PARS percent reductions and absolute cut-off scores in predicting treatment response and remission, as determined by posttreatment ratings on the Clinical Global Impression scales and the Anxiety Disorders Interview Schedule for DSM-IV. Corresponding change in impairment was evaluated using the ChildAnxiety Impact Scale. RESULTS: Reductions of 35% and 50% on the six-item PARS optimally predicted treatment response and remission, respectively. Post-treatment PARS raw scores of 8 to 10 optimally predicted remission. Anxiety improved as a function of PARS-defined treatment response and remission. CONCLUSIONS: Results serve as guidelines for operationalizing treatment response and remission in future research and in making cross-study comparisons. These guidelines can facilitate translation of research findings into clinical practice.
Authors: Corinne Hannan; Michael J Lambert; Cory Harmon; Stevan Lars Nielsen; David W Smart; Kenichi Shimokawa; Scott W Sutton Journal: J Clin Psychol Date: 2005-02
Authors: Philip C Kendall; Scott N Compton; John T Walkup; Boris Birmaher; Anne Marie Albano; Joel Sherrill; Golda Ginsburg; Moira Rynn; James McCracken; Elizabeth Gosch; Courtney Keeton; Lindsey Bergman; Dara Sakolsky; Cindy Suveg; Satish Iyengar; John March; John Piacentini Journal: J Anxiety Disord Date: 2010-02-06
Authors: Elizabeth B Owens; Stephen P Hinshaw; Helen C Kraemer; L Eugene Arnold; Howard B Abikoff; Dennis P Cantwell; C Keith Conners; Glen Elliott; Laurence L Greenhill; Lily Hechtman; Betsy Hoza; Peter S Jensen; John S March; Jeffrey H Newcorn; William E Pelham; Joanne B Severe; James M Swanson; Benedetto Vitiello; Karen C Wells; Timothy Wigal Journal: J Consult Clin Psychol Date: 2003-06
Authors: Scott N Compton; John T Walkup; Anne Marie Albano; John C Piacentini; Boris Birmaher; Joel T Sherrill; Golda S Ginsburg; Moira A Rynn; James T McCracken; Bruce D Waslick; Satish Iyengar; Phillip C Kendall; John S March Journal: Child Adolesc Psychiatry Ment Health Date: 2010-01-05 Impact factor: 3.033
Authors: Joseph F McGuire; Nicole E Caporino; Sophie A Palitz; Philip C Kendall; Anne Marie Albano; Golda S Ginsburg; Boris Birmaher; John T Walkup; John Piacentini Journal: Depress Anxiety Date: 2019-06-24 Impact factor: 6.505
Authors: Sophie A Palitz; Nicole E Caporino; Joseph F McGuire; John Piacentini; Anne Marie Albano; Boris Birmaher; John T Walkup; Scott N Compton; Golda S Ginsburg; Philip C Kendall Journal: J Am Acad Child Adolesc Psychiatry Date: 2018-04-17 Impact factor: 8.829
Authors: Jerome H Taylor; Eli R Lebowitz; Ewgeni Jakubovski; Catherine G Coughlin; Wendy K Silverman; Michael H Bloch Journal: J Clin Child Adolesc Psychol Date: 2017-09-28
Authors: Nicole E Caporino; Dara Sakolsky; Douglas M Brodman; Joseph F McGuire; John Piacentini; Tara S Peris; Golda S Ginsburg; John T Walkup; Satish Iyengar; Philip C Kendall; Boris Birmaher Journal: J Am Acad Child Adolesc Psychiatry Date: 2017-06-06 Impact factor: 8.829
Authors: Carly J Johnco; Alessandro S De Nadai; Adam B Lewin; Jill Ehrenreich-May; Jeffrey J Wood; Eric A Storch Journal: J Autism Dev Disord Date: 2015-10
Authors: Autumn Kujawa; Anna Weinberg; Nora Bunford; Kate D Fitzgerald; Gregory L Hanna; Christopher S Monk; Amy E Kennedy; Heide Klumpp; Greg Hajcak; K Luan Phan Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2016-08-02 Impact factor: 5.067
Authors: Rinad S Beidas; Oliver Lindhiem; Douglas M Brodman; Anna Swan; Matthew Carper; Colleen Cummings; Philip C Kendall; Anne Marie Albano; Moira Rynn; John Piacentini; James McCracken; Scott N Compton; John March; John Walkup; Golda Ginsburg; Courtney P Keeton; Boris Birmaher; Dara Sakolsky; Joel Sherrill Journal: Behav Ther Date: 2013-05-16